ReviewBlood neoplasia2026

Addition of anti-CD38 mAb in newly diagnosed multiple myeloma: advancing toward quadruplet induction regimens.

Yuqi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.